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ABSTRACT
Objective Cardiovascular disease is an underappreciated 
issue in prison medicine. Recent studies have revealed a 
higher prevalence of cardiovascular disease risk factors 
(CVDRFs) among individuals in prison, but the impact of 
incarceration on CVDRFs over time is not well understood. 
This review aimed to assess available literature and 
quantify the relationship between incarceration and trends 
in major CVDRFs in high- income countries.
Design Systematic review following the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses statement. Meta- regression on weight change 
and obesity.
Data sources Medline, Embase, PubMed, Cochrane 
Central Wiley and Web of Science.
Eligibility criteria for selecting studies Longitudinal 
studies reporting on the incidence of, or trends in any 
CVDRF among current or former people in prison over 
time, in high- income countries.
Data extraction and synthesis Two authors 
independently screened articles for eligibility, extracted 
data and assessed quality using an adapted version of the 
Newcastle- Ottawa Scale. Trends in CVDRFs during and 
following incarceration were summarised and in those 
with sufficient data a meta- regression was performed.
Results Twenty- six articles were identified. CVDRFs 
assessed included obesity, hypertension, diabetes, 
dyslipidaemia, tobacco use, physical inactivity and 
unhealthy diet. A meta- regression on change in weight 
during incarceration found a mean increase of 5.3 kg 
(95% CI 0.5 to 10.1) and change in body mass index of 
1.8 kg/m2 (95% CI −0.9 to 4.6) at 2 years. Weight gain 
appeared most pronounced right after entering prison 
and then plateaued at 2 years. Concerning hypertension, 
the results were inconclusive, despite a trend towards 
rising blood pressure or prevalence of hypertension during 
incarceration, and an increased incidence of hypertension 
following incarceration. Results are contradictory or 
inconclusive for the other CVDRFs reviewed.
Conclusion Possible explanations for the association 
between incarceration and weight include a sedentary 
lifestyle, unhealthy diet, forced smoking cessation, 
psychotropic medication use and high levels of stress. 




Cardiovascular disease (CVD) is the leading 
cause of death worldwide1 and among the 
primary causes of disability.2 CVD is also a 
leading cause of death in people currently 
or previously incarcerated.3 In 2018, in the 
USA, over 2.1 million people experienced 
incarceration, amounting to 0.65% of the US 
population, nearly five times the rate in the 
UK.4 This disproportionately affects African- 
American men in whom it has been estimated 
that up to a third have had contact with the 
prison system.5 Furthermore, in high- income 
countries, the prison population is growing 
older along with the general population and 
it is estimated that one- third of the US prison 
population will be over 55 by 2030.6 Like the 
general population, older people in prison 
have a different and more complex health 
Strengths and limitations of this study
 ► Our statistical approach (a random- effects meta- 
regression model) allowed us to assess the dose- 
response relationship between time spent in prison 
and weight and body mass index changes.
 ► The methodology used to assess the relationship 
between time spent in prison and changes in weight 
can contribute to a better understanding of the tem-
poral relationship between weight gain and incar-
ceration and help identify key mediating factors.
 ► The uncertainty in the estimates of the meta regres-
sion were high due to the small number of included 
studies, reflected by the large CIs.
 ► Substantial heterogeneity between studies, includ-
ing differences in prison contexts and population 
characteristics, limited our ability to draw clear con-
clusions about which factors contribute to the trends 
in CVDRFs described.
 ► Findings have limited generalisability to low- income 
or middle- income countries given they were exclud-
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profile, and in particular, a higher incidence of chronic 
diseases.7 Currently, clinical guidelines8 9 and research 
in prison medicine tend to focus on infectious diseases, 
substance use, psychiatric disorders and trauma.10 With 
this demographic shift towards older prison populations 
there is a need to better understand trends in chronic 
conditions that are expected to emerge.
Recently, there is growing evidence that people in 
prison experience a high prevalence of CVDRFs including 
hypertension (HTN), obesity, diabetes and tobacco use, 
compared with the general population.11–17 In the USA, 
this trend is especially evident among women in prison.18 
Furthermore, about 80%19–21 of prisoners are smokers, 
which is 1.7–8 times higher than the general popula-
tion.22 Conversely, other evidence18 23 suggests a lower 
level of obesity among people in prison compared with 
the general population, challenging the common belief 
that the prison environment is detrimental to health.
It is unclear whether the prison environment is the 
cause of health issues or whether it mirrors an overrep-
resentation of morbid people or people with pre- existing 
CVD risks factors.12 There is a gap of knowledge about 
the impact of incarceration on the emergence or change 
in major CVDRFs over time. To address this knowledge 
gap, this review aims to summarise and quantify, where 
possible, the relationship between incarceration and 
trends in major CVDRFs over time including obesity 
(weight gain), HTN, diabetes, tobacco use, dyslipidaemia, 




A literature search was conducted with the assistance of a 
medical librarian in five databases: Medline Ovid SP (1946 
to December 2018),  Embase. com (1947 to December 
2018), PubMed (1946 to December 2018) with restriction 
to non- Medline articles, Cochrane Central Wiley and Web 
of Science Core Collection (1900 to December 2018). 
All keywords, MeSH and Emtree terms that describe 
prison, and major CVDRFs were used, including obesity 
(including the concepts of body mass index (BMI), or 
weight), HTN, diabetes (DM), dyslipidaemia, tobacco 
use, physical inactivity and unhealthy diet. The type of 
study, or population type was not specified at this stage. 
The detailed search strategy is available in the online 
supplemental appendix A. Additional studies were iden-
tified through a review of all references in the included 
articles.
Screening articles for eligibility
Two authors (CB and AA) independently screened arti-
cles for eligibility in two phases: 1) screening by a title and 
abstract and 2) a full- text screening. Disagreements that 
could not be resolved between CB and AA were resolved 
through discussion with a third author (PB).
Inclusion and exclusion criteria
Studies reporting at least two values of any CVDRFs at two 
different time points, or studies that described the inci-
dence of any CVDRF, irrespective of the baseline CVDRFs 
of the population, were included. Only studies conducted 
in high- income countries were eligible. The full eligibility 
criteria used during screening can be found in table 1.
Data extraction
The data extracted from each article included: study 
design, study population characteristics (sex, age), time 
already served at baseline and follow- up duration. In 
cases where the same study population was used in several 
studies, only the results of the main study were reported 
(ie, the one with more participants or CVDRF evalua-
tions). For all studies, we also extracted and reported the 
first and last value of each CVDRF or its incidence rate. 
For randomised controlled trials (RCTs), only the values 
in the control arm were extracted. When needed, study 
authors were contacted by email to verify their method-
ology or to request additional data.
Quality appraisal
The quality of each article was assessed independently 
by CB and AA. A quality scale of 1–8 was created based 
on the Newcastle- Ottawa Scale for quality assessments of 
cohort studies.24 Articles with 1–3 stars were considered 
of poor quality, 4–6 stars of moderate quality and 7–8 stars 
of good quality. The scores are indicated with star symbols 
(⁕) in table 2.
Statistical methods
Findings for all associations between incarceration and 
individual CVDRFs were reported using descriptive statis-
tics. The data on mean follow- up time, weight and BMI 
changes from baseline, along with SEs, were extracted and 
presented on a forest plot with studies sorted according 
to the mean follow- up time. As the forest plot clearly 
exhibited both the presence of strong heterogeneity and 
a dose- response relation of the outcomes with time, we 
conducted a random- effects meta- regression analysis. 
Estimation was carried out by restricted maximum like-
lihood. Based on the regression coefficients, the dose- 
response relationship between time spent in prison and 
each of the outcomes (ie, change in weight and BMI over 
time) were graphed on scatter plots with the size of the 
points (or ‘bubbles’) proportional to the precision of the 
effect size estimates. A pointwise CI around the regres-
sion line was computed. We used Stata V.15 (StataCorp, 
College Station, Texas, USA) to conduct the statistical 
analysis. Due to insufficient data, no statistical analysis 
could be performed on all other CVDRFs assessed in this 
review.
Patient and public involvement
Due to the nature of our systematic review (ie, not original 
research), it was not appropriate or possible to involve 
patients or the public in the design, conduct, reporting 
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RESULTS
The Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses flow chart (figure 1) summarises the 
study selection process. A total of 5494 articles were 
identified through the prespecified search strategy (see 
online supplemental appendix A). Twenty- six articles 
met criteria for inclusion in the final analysis, of which 22 
reported on unique study populations. One author25–27 
published three papers on the same population, and 
another two authors28–31 published two papers.
Ten authors29 32–40 were contacted due to missing data 
or difficulties interpreting study results in the published 
papers. One40 responded that the data were no longer 
available. Four others were able to share results33 34 37 or 
assist in their interpretation.29 The remaining authors 
could not be reached. A summary of the 22 included 
studies is provided in table 2. Three studies were rated 
of good quality, 13 of moderate quality and 4 of poor 
quality. A table summarising the quality assessments for 
each article is available in online supplemental appendix 
B. The majority of studies addressed CVDRFs during 
incarceration. Only three studies addressed changes in 
CVDRFs following incarceration.36 39 41
In the following sections, all studies followed by a star 
(‘*’) reported a statistically significant value (p<0.05) for 
the difference between baseline and end of follow- up for 
the CVDRF of interest.
Hypertension
Seven studies addressed the impact of incarceration 
on blood pressure (BP).30 32 38 39 42–44 In four studies the 
mean level of BP rose during incarceration.32 38 42 43 Two 
studies30 38 found a non- significant increase in the number 
of people in prison suffering from HTN during incar-
ceration (+2.5% and+0.6 %, respectively). One study, 
derived from a US cohort followed for 5 years after incar-
ceration, reported a 12% cumulative incidence of HTN 
among ex- prisoners compared with 7% among non- ex- 
prisoners.39* This difference was particularly marked in 
those who were less educated and in black men. One study 
focusing on the concept of crowding found that people in 
prison who moved from individual cells to dormitory- style 
cells experienced a small but statistically significant mean 
rise in systolic BP of 2.6 mm Hg.42* However, this effect was 
reversible when they moved back to an individual cell. In 
contrast, one Japanese study showed a significant decrease 
in BP44* during incarceration over a 1- year period.
Diabetes
Five studies addressed trends in diabetes during incar-
ceration.35 39 45–47 Three reported an improvement in 
Table 1 Eligibility criteria
Inclusion criteria Exclusion criteria
Population
  Adults (aged ≥18 years) Children or adolescents
  Men and women Custody, community correction supervision (eg, probation, 
parole) or war prisoner
  Current or ex- prisoners Focused only on people in prison with a specific health 
condition like chronic infectious diseases (HIV, hepatitis, 
etc), mental disease or addiction, unless a control group 
exists
  High- income country   
Languages
  English, French, Spanish, Portuguese, German, Italian   
Duration
  Minimum 2 weeks follow- up <2 weeks
Study type
  Longitudinal or cohort studies prospective or retrospective Systematic reviews, conference proceedings, book 
reviews, commentaries, fact sheets, discussion or policy 
statements
  Randomised controlled trials or intervention studies only if a 
control group exists




  Changes in major CVDRFs levels during or after incarceration at 
two independent timepoints
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the control of one’s diabetes, reflected by a decrease in 
haemoglobin A1c (HbA1c)35 46 47* and reduced fasting 
blood glucose (FBG).46* Interestingly, one study from 
Japan46* showed a significant decrease in mean HbA1c 
from 8.4% to 5.9% over 14 months. To explore the link 
between food served and the control of one’s diabetes, 
Firth et al compared people in prison receiving a new 
reduced calorie menu (RCM) implemented by the prison 
administration (ie, not a research intervention) offering 
2200 kcal/day to those still receiving the normal menu 
(NM) with 3000 kcal/day.35 Improvements in mean 
HbA1c were reported in both groups, but the decrease 
was significantly more marked in the RCM group 
compared with the NM group. Davoust et al45 found a 
statistically non- significant rise of 0.26% in HbA1c during 
the 3 months of follow- up in a cohort of 15 people. Lastly, 
one paper found that ex- prisoners were not at higher risk 
of developing DM after incarceration than those who had 
never been incarcerated.39
Tobacco use
Five articles25–27 38 41 describing three original studies25 38 41 
(one in which tobacco use was prohibited in the study 
setting41) addressed trends in tobacco use during and 
following incarceration. In prisons without a smoking 
ban, the incidence of smoking did not change signifi-
cantly between baseline and follow- up, which ranged 
from 1 to 6 months.25 38 One study reported a significant 
decrease in the quantity of tobacco smoked 1 month after 
entering prison (from 19.9 g to 11.7 g/day).38* In the 
study by Cropsey et al,25 the fact that 2.8% of the smokers 
quit was counterbalanced by the fact that another 14.2% 
self- reporting that they started smoking for the first time 
in prison.25 Moreover, in another study, it was found that 
50.8% of smokers increased their consumption after 
entering prison compared with 15.8% who decreased 
their consumption.25 The self- reported increase in 
tobacco consumption during incarceration was especially 
marked among African- American smokers in one all- 
female cohort.27 Finally, one study found that that 92.8% 
of smokers had relapsed at 3 weeks following release41 
from a tobacco- free prison.
Dyslipidaemia
Four articles addressed the association between dyslip-
idaemia and incarceration with conflicting find-
ings.32 43 44 46 Two reported an increase in total cholesterol 
(TC), low- density lipoprotein (LDL) and triglycerides 
(TG) levels32 43 and a decrease in high- density lipopro-
tein (HDL) during incarceration.32 However, these 
changes either did not reach statistical significance or 
the level of statistical significance was not reported. In 
contrast, both Japanese papers on this topic found a 
statistically significant decrease in TC during incarcer-
ation.44 46*
Physical inactivity and unhealthy diet
One study by Plugge et al38 addressed the association 
between physical activity, diet and incarceration in a 
cohort of 220 women in prison in the UK. What they 
found was a low level of physical activity at entry into 
prison and no significant change at a 1 month follow- up. 
They also found a statistically non- significant decrease in 
women following the recommended healthy diet each 
day from 13.4% to 8.3% during the same time period.
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Weight and obesity
Eighteen studies addressed the association between 
weight and incarceration.29–38 40 48–50 Thirteen31 33 37 38 40 48 49 
reported either a positive change in the prevalence of 
people in prison being overweight and obese or an increase 
of weight or BMI during or after incarceration.29–38 40 48–50 
The identified risk factors for weight gain during incar-
ceration in the reviewed studies included being a black 
man,36 being a woman25 34 37 (especially women who quit 
smoking during incarceration26) and taking antidepres-
sants or antipsychotics.29
Five studies report a decrease in BMI or weight in 
relation to incarceration: one Japanese study44* found a 
change in BMI of −1.0 kg/m2 over 12–14 months of incar-
ceration, two found trends towards decreased weight25 of 
−1.86 kg and BMI43 of −0.1 kg/m2 that did not meet statis-
tical significance, and two reported ‘little change’42 or ‘no 
significant change in BMI’47 without providing quantita-
tive data.
Meta-regression
To summarise findings related to changes in weight and 
BMI from baseline to follow- up, study effect sizes were 
graphed on a forest plot in order of increasing length of 
follow- up. There were marked differences in follow- up 
time between studies, ranging from 0.5 to 60 months. 
Consequently, no overall summary index could be 
computed at this stage. Despite this limitation, the forest 
plots (figures 2 and 3) illustrate that the majority of results 
lie on the positive side (ie, side of increase) in both the 
change in weight and change in BMI. In a second stage, 
in order to assess the overall change in weight and BMI 
over time, we carried out a meta- regression on the change 
in weight (figure 4) and BMI (figure 5) during incarcer-
ation. Five studies32 35 43 44 49 could not be included in the 
computation as they lacked necessary data (ie, unavail-
able SEs) and we were unable to reach the authors to 
gather the required data. These studies were represented 
by a simple dot on the plots as shown in figures 2 and 3. 
It was found that the mean weight gain during incarcer-
ation was 0.30 kg (95% CI −0.03 to 0.6) at 1 month, 3.1 
kg (95% CI −0.01 to 6.3) at 1 year and 5.3 kg (95% CI 0.5 
to 10.1) at 2 years. The mean increase in BMI was 1.1 kg/
m2 (95% CI −0.7 to 2.9) at 1 year and 1.8 kg/m2 (95% CI 
−0.9 to 4.6) after 2 years of incarceration. The τ2 was 10.3 
for the change in weight and 1.7 for the change in BMI.
DISCUSSION
The results of this study showed that the mean weight 
or BMI of the people in prison in high- incomes coun-
tries seemed to increase during incarceration. This 
effect appears most pronounced in the first 2 years of 
Figure 2 Weight change during incarceration (forest plot). The follow- up periods between studies ranged from 0.5 to 60 
months. Due to the presence of strong heterogeneity and the fact that there is a dose- response relation of the outcomes 
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incarceration and levels off beyond 2 years. Of the seven 
studies that addressed the relationship between incar-
ceration and HTN, six showed a trend towards either 
an increasing blood pressure or the prevalence of HTN 
during incarceration, or an increased incidence of HTN 
following incarceration. However, as the majority of these 
results were not statistically significant, the relationship 
between incarceration and the evolution of HTN remains 
unclear. For all other CVDRFs assessed, the results were 
contradictory or inconclusive limiting our ability to draw 
any clear conclusions about the impact of incarceration 
on the trends in these CVDRFs over time based on the 
available evidence.
Weight and obesity
By conducting a meta- regression on available data relating 
to incarceration and change in weight and BMI over time, 
an overall rise in weight and BMI during incarceration was 
found. In figures 4 and 5, a steeper slope in weight and 
BMI over time (ie, more pronounced change) was seen 
at the beginning of incarceration, particularly during the 
first few months, and appeared to level off after 2 years. 
Compared with the average weight gain of the middle- 
aged US population, estimated to be between 0.5 and 1 
kg/year,51 the mean weight gain found in this review was 
up to five times higher in the first 2 years of imprisonment. 
Hypothesised reasons for this include a combination of a 
sedentary lifestyle and a poor diet (the high calorie meals 
served in prison and the extra snacks or sweet beverages 
purchased from the commissary store),11 52 53 forced 
smoking cessation (which has been associated with weight 
gain54), a high prevalence of people in prison taking 
psychotropic medication (known to affect weight),11 high 
rates of depressive symptoms55 and high levels of stress.56 
Many of these factors are interconnected which might 
create a vicious cycle of weight gain. For instance, it has 
been found that depression increases the odds of devel-
oping obesity among people in prison, while obesity may 
increase the risk for depression.57 Furthermore, current 
or recent incarceration is associated with depression and 
mood disorders,58 59 and chronic stress is associated with 
poor eating behaviours and obesity.60 However, how and 
to what extent these diverse factors contribute to weight 
gain among people in prison remains unclear. To further 
complicate the issue, a recent systematic review23 found 
that 42%–75% of people in prison gained weight while 
incarcerated which was thought to be due to importing 
poor health behaviours from the community into prison, 
as well as individuals adapting to the prison environment 
by building muscles to demonstrate strength among 
peers. As such, the authors of this review highlight that 
BMI may be a poor marker of weight gain in prison 
because bodybuilding positively changes the ratio of fat- 
to- muscle mass raising the BMI while potentially reducing 
cardiovascular risk. However, the extent to which physical 
Figure 3 Body mass index (BMI) change during incarceration (forest plot). The follow- up periods between studies ranged from 
6 to 60 months. Due to the presence of strong heterogeneity and the fact that there is a dose- response relation of the outcomes 
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training can explain the rising prevalence of weight gain 
in people in prison during incarceration is unknown.
In terms of the long- term impact of incarceration on 
weight gain, only one study addressed this issue by exam-
ining weight gain in a large US- based cohort (n=61 200) 
of ex- prisoners with a follow- up of 25 years. The authors 
concluded that those incarcerated or with a history of 
incarceration have a higher increase in BMI over time, 
especially for black people in prison and those with lower 
education, compared with non- exprisoners.36 Nonethe-
less, the quality of this study was judged poor, and the 
growth curve models used were hard to interpret in detail.
A meta- analysis61 published in 2018 examining a similar 
question to our current systematic review (ie, association 
between weight gain and incarceration) reported a posi-
tive weight change during incarceration, with a mean 
increase of 0.43 lbs (0.19 kg) per week. Implicitly, these 
authors assumed a linear gain in weight over time. Our 
results, however, challenge this hypothesis by showing 
that weight gain may not be linear throughout incarcer-
ation but instead may increase steeply during the initial 
period of incarceration and then plateau over time.
Explanations for the more pronounced weight change 
noted among women in one of the reviewed28 study 
include a smaller number of facilities and programmes 
in female prisons leading to fewer recreational activities 
and a more sedentary lifestyle; meals served containing 
the same amount of calories as those served to men18 and 
more antipsychotic medications prescribed to women 
than men in prisons.62 The only study reporting a signif-
icant decrease in BMI in this review was conducted in 
Japan, whose findings were likely due to low calorie diets 
and food restrictions implemented in Japanese prisons. 
Further studies are needed to elucidate whether the 
weight loss seen in this study is due to healthy weight loss 
or weight loss caused by high- stress prison conditions.
Hypertension
Among available studies examining the association 
between HTN and incarceration, all but one showed a 
trend over time towards either a rise in BP during incar-
ceration,32 38 42 43 a higher prevalence of HTN among 
people in prison30 38 or a higher incidence of HTN in 
people released from prison compared with those never 
incarcerated.39 Few driving factors have been hypothe-
sised to explain this unconfirmed and non- significant 
trend. Although most findings were statistically non- 
significant, trends towards an increase in BP or in the 
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prevalence of HTN during incarceration seems highly 
plausible due to a number of factors discussed throughout 
the reviewed studies. First, prison crowding,42 whereby 
people in prison are confined to a limited space and 
exposed to high noise stress, with an increased number of 
threatening interactions with other prisoners and guards. 
Second, incarceration conditions are inherently stressful, 
and the link between psychosocial stress and HTN is well 
established.63 Third, the sedentary lifestyle of people in 
prison may contribute to weight gain, which is also associ-
ated with an increase in BP.64 Finally, despite institutional 
efforts made in many prisons to reduce dietary sodium,65 
high salt diets are often still served.38 66 Interestingly, 
working42 44 appears to be a protective factor against HTN 
during incarceration. The causes for this association are 
not clear but it is plausible that work might contribute 
to a more active lifestyle or help reduce stress levels 
during incarceration. The explanation for the significant 
decrease in BP reported by Nara and Igarashi44 could 
be related to the specific prison environment, which is 
described in the two Japanese articles included in this 
review.44 46 The very strict detention conditions include 
a smoking ban, calorie restriction for all (1800 kcal/day 
for women and 2500 kcal/day for men), prohibition to 
eat between meals and at night and a ban on extra food 
like snacks or sweetened drinks. Finally, the persisting 
effect of incarceration on HTN after release found in one 
study39* might be explained by psychosocial factors due 
to the ongoing stress caused by adaptations required to 
life outside prison, including a limited access to employ-
ment and changes in social relationships for ex- prisoners. 
Further research is needed into the causal factors behind 
this association between HTN and incarceration, well 
beyond the time of incarceration.
Diabetes
Three of the four studies that looked at changes in blood 
sugar control during incarceration point to better blood 
sugar control during incarceration. However, of these 
three studies,35 46 47 one was conducted in Japan in a 
prison setting with calorie restriction for all prisoners,46 
and one35 showed the most pronounced effect in those 
receiving a RCM (2200 kcal/day). For both studies, the 
main driver of improved blood sugar control may have 
been be the calorie reduction instead of incarceration 
itself. Other explanations could be that some aspects of 
prison life contribute to improved blood sugar control 
such as the provision of regular meals and daily access 
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to the prison yard and scheduled sports, providing more 
opportunities for better eating and physical activity than 
prior to incarceration. It should also be considered that 
some individuals may have had limited access to health-
care prior to incarceration which may have adversely 
impacted their diabetes control.18 67 Finally, despite a 
higher odd of DM seen among people in prison,12 only 
one study identified in this review looked at the associa-
tion between incarceration and the incidence of DM in 
people released from prison compared with those never 
incarcerated, in which no significant association was 
found.39
Tobacco use
The prevalence of smoking among people in prison is 
very high.19–22 Surprisingly, very few longitudinal studies 
were identified that assessed the change in smoking 
habits during incarceration that did not involve the 
evaluation of a smoking cessation intervention. The 
only study identified in this review that addressed this 
question was by Plugge et al,38 who reported a decrease 
in the quantity of tobacco consumed during incarcer-
ation. However, the follow- up was only 1 month, and 
started right after entering prison, which raises the 
question of the accessibility of tobacco in the first days 
to weeks of incarceration. Overall, further studies are 
needed to better understand the impact of incarceration 
on tobacco use. The public health response to the high 
prevalence of smoking in prisons in some countries has 
been to implement smoking bans, including in many 
states across the USA68 as well as in Japan. However, rules 
vary considerably by country and region,69 as smoking 
bans were not reported in the French,37 45 Italian32 50 and 
English38 47 prisons described in the included studies. 
Although smoking bans appeared to be beneficial in 
reducing the health impacts of tobacco use, such as 
in- prison mortality,70 the impact that smoking bans have 
on long- term tobacco use is inconsistent in the current 
literature. One study71 showed that a majority (76%) of 
men in prison continued to smoke 1 month after the 
implementation of a smoking ban. Moreover, resump-
tion after release from a smoke- free prison appears 
to be very high in the few studies reporting on this 
topic.41 70 72–75 For instance, according to one system-
atic review,76 >60% of former smokers relapsed on the 
first day after release, and almost all resumed smoking 
within 6 months of release. Despite this high rate of 
relapse another systematic review,77 based on many of 
the same studies, commented that the rate of relapse 
varied too much to draw any clear conclusions. Finally, 
another review22 found a similar efficacy of counselling 
and behavioural interventions aimed at smoking cessa-
tion in a prison setting when compared with a commu-
nity setting, thus highlighting the potential benefits 
of pharmacological and psychological interventions 
in prisons to reduce high tobacco consumption and 
supporting sustained smoking cessation.
Dyslipidaemia, physical inactivity and unhealthy diet
A previous systematic review highlighted that the food 
served in prison settings was atherogenic, lacking in 
fruits and vegetables and with high saturated fat and 
sodium content above the recommended limits.11 
However, due to limited findings regarding trends over 
time of dyslipidaemia, physical inactivity and unhealthy 
diet in relation to incarceration identified in this review, 
no conclusions could be drawn. Further research in this 
area is required.
Strengths and limitations
Some limitations of this systematic review require consid-
eration. First, there is a high degree of uncertainty in 
the estimates of the meta- regression curve produced 
in the analysis. This is due to the small number of 
included studies and the substantial residual between- 
study variances as reflected by the large CIs. In addition, 
we found substantial heterogeneity between studies, 
which may be attributable to differences in incarcera-
tion conditions that were not accounted for within indi-
vidual studies. Moreover, differences in prison contexts 
and population characteristics may have also influ-
enced changes seen in CVDRFs during incarceration 
such as: smoking bans, the prison security level, access 
to regular physical activity, the type and quantity of food 
served and purchased, access to and frequency of work 
and whether those studied were facing incarceration for 
the first time or had been exposed to multiple periods 
of incarceration. Only studies from high- income coun-
tries were included, thus limiting the generalisability of 
our results to low- income or middle- income countries. 
Lastly, the literature search was conducted in December 
2018, and more recent publications could change some 
of our findings. We were unable to conduct an updated 
search prior to publication.
The main strength of this review is that our statistical 
approach (a random- effects meta- regression model) 
allowed us to assess the dose- response relationship 
between time spent in prison and changes in weight 
and BMI over time. This methodology might help shift 
the focus in this area of research to improve our under-
standing of the temporal relationship between weight 
gain and incarceration and identify key mediating 
factors.
CONCLUSION AND RECOMMENDATIONS
This review reinforces previous results of a positive asso-
ciation between weight gain and incarceration but newly 
highlights that this effect may be most pronounced 
during the first 2 years of incarceration. These find-
ings could allow us to think about incarceration like 
an aggregate adverse determinant of health serving 
as an important part of our clinical history taking (ie, 
whether someone has been previously incarcerated 
or not) when assessing individual cardiovascular risk. 
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a trend towards either a rise in blood pressure or a 
raising prevalence of HTN during incarceration, and in 
one study a higher incidence of HTN among ex- pris-
oners compared with non- ex- prisoners. More studies 
are needed to confirm or overrule this tendency.
Since this review only focused on studies conducted 
in high- income countries, further research should be 
encouraged on a global scale to improve our under-
standing of the relationship between incarceration and 
CVDRFs over time. Despite prior reviews reporting a 
higher prevalence of most other CVDRFs including 
smoking, dyslipidaemia, unhealthy diet and physical inac-
tivity, we could not conclude whether there was a positive 
(or negative) trend over time during or after incarcera-
tion given the current available literature. More studies 
are needed to fill this gap.
Primary prevention and treatment of non- 
communicable diseases including CVD in prison have 
largely been neglected.21 The prison setting offers 
unique opportunities for the prevention and manage-
ment of CVDRFs, as its milieu is controlled in terms of 
daily physical activity or work, caloric intake, tobacco 
availability and access to healthcare. The Japanese prison 
environment proved to be very efficient at controlling 
or improving diabetes, HTN and BMI, however such 
conditions might not be appropriate for all countries or 
cultures and may have other deleterious effects that have 
not yet been explored (ie, excessive weight loss, increased 
stress or depressive mood) in comparison to less strict 
prison environments. Interventions involving structured 
physical activity, diet modification, nutrition education 
and smoking cessation can improve the cardiovascular 
health of people in prison while incarcerated.19 Addi-
tional efforts should be made to support those taking 
antipsychotic or antidepressant drugs in order to avoid 
worsening CVDRFs through associated weight gain and 
dyslipidaemia. Furthermore, due to possible beneficial 
effects on CVDRFs, we would recommend that people in 
prison have access to work that facilitates regular physical 
activity in order to tackle the inactivity and psychosocial 
stress inherent to the prison environment. Future studies 
should focus on the mediating factors in the relationship 
between incarceration and major CVDRFs.
Finally, due to the ubiquity of bodybuilding in prisons, 
studies in this area should consider reporting waist 
circumference, which may be a better marker of weight 
gain or obesity than BMI or weight gain in the prison 
context.23
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